Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIIL LAIV in children 24-59 months in Bangladesh
NCT01625689Phase 2Completed
- Sponsor
- PATH Vaccine Solutions
- Start
- Jun 2012
- Primary completion
- Feb 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of live attenuated influenza vaccine in influenza, sponsored by PATH Vaccine Solutions. Started Jun 2012; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01625689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01625689.